Fastin-XR
This product is no longer available
This product was taken off the market by the manufacturer around Jul 24, 2015
Product Type
supplement
Packaging Size
Serving Size
1.0 Capsule(s)
UPC
857084000675
Ingredients
fastin extended release proprietary blend | 375.0 | mg |
phenylethylamine alkoloids | 200.0 | mg |
caffeine anhydrous | 150.0 | mg |
Description
THE WORLD'S MOST ADVANCED WEIGHT LOSS AID EVER DEVELOPED WITH EXTENDED RELEASE TECHNOLOGY! 525 mg EXTENDED RELEASE CAPSULES REVOLUTIONARY FAT LOSS CATALYST & APOPTOSIS AGENT PEEL HERE To report adverse effects call FDA's MedWatch at 1.800.332.1088
Formulation
Precautions
IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. AVOID ALCOHOL WHILE TAKING THIS PRODUCT. DO NOT EXCEED RECOMMENDED SERVING. EXCEEDING RECOMMENDED SERVING MAY CAUSE SERIOUS ADVERSE HEALTH EFFECTS, INCLUDING HEART ATTACK AND STROKE. DISCONTINUE USE AND CALL A PHYSICIAN OR LICENSED QUALIFIED HEALTH CARE PROFESSIONAL IMMEDIATELY IF YOU EXPERIENCE RAPID HEARTBEAT, DIZZINESS, SEVERE HEADACHE, SHORTNESS OF BREATH, OR OTHER SIMILAR SYMPTOMS. IMPROPER USE OF THIS PRODUCT MAY BE HAZARDOUS TO A PERSON'S HEALTH. EXCEEDING RECOMMENDED SERVING WILL NOT IMPROVE RESULTS. WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS. SALE TO PERSONS 17 YEARS OF AGE OR YOUNGER IS PROHIBITED DO NOT USE IF YOU ARE PREGNANT OR NURSING. Tamper Evident
Do Not Use If Printed Seal Is Cut, Torn or Missing INDIVIDUALS WHO CONSUME CAFFEINE WITH THIS PRODUCT MAY EXPERIENCE SERIOUS ADVERSE HEALTH EFFECTS. INDIVIDUALS WHO ARE SENSITIVE TO THE EFFECTS OF CAFFEINE SHOULD CONSULT A LICENSED HEALTH CARE PROFESSIONAL BEFORE CONSUMING THIS PRODUCT.
(WARNING.INFORMATION CONTINUED ON BACK OF LABEL.)